IVBT (Innovation1 Biotech) EBITDA Margin %: 0.00% (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech EBITDA Margin %?

Innovation1 Biotech IVBT 12 EBITDA Margin % is 0.00% as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovation1 Biotech's EBITDA for the three months ended in Feb. 2024 was $-0.15 Mil. Innovation1 Biotech's Revenue for the three months ended in Feb. 2024 was $0.00 Mil. Therefore, Innovation1 Biotech's EBITDA margin for the quarter that ended in Feb. 2024 was 0.00%.

Innovation1 Biotech  (OTCPK:IVBT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Innovation1 Biotech EBITDA Margin % Related Terms

Innovation1 Biotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech EBITDA Margin % Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -212.66 -128,000.00 42,033.33 0.00 0.00

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IVBT vs NVIV, PXMD, SCNI: EBITDA Margin % Comparison

For the Shell Companies subindustry, Innovation1 Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation1 Biotech EBITDA Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's EBITDA Margin % falls into.


IVBT
12GF Score
Innovation1 Biotech Inc IVBT
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innovation1 Biotech's EBITDA Margin % for the fiscal year that ended in Aug. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=-5.684/0
= %

Innovation1 Biotech's EBITDA Margin % for the quarter that ended in Feb. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-0.15/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Innovation1 Biotech (IVBT) has a EBITDA Margin % of 0.00% as of Feb. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's EBITDA Margin % too high?
Innovation1 Biotech's current EBITDA Margin % is 0.00%. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's EBITDA Margin % compare to NVIV and PXMD?
Innovation1 Biotech's EBITDA Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median EBITDA Margin % is 11.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Diversified Financial Services company?
The median EBITDA Margin % among Diversified Financial Services companies is 11.75, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovation1 Biotech and its competitors. For the Diversified Financial Services industry, the median EBITDA Margin % is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovation1 Biotech's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current EBITDA Margin % is 0.00% as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price